Faeth Therapeutics, Inc. (FTH) stock
FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.65−2.70 (-20.22%)
Close on Nov 12, 2026Market cap $275.20MP/E –Yield –
Faeth Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Faeth Therapeutics's ebitda for the twelve months ending Jun 30, 2026 was -$198.71M. For fiscal 2025 it was -$22.17M. The highest annual figure on record is -$19.24M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.17M | – |
| FY2024 | Dec 31, 2024 | -$32.06M | – |
| FY2023 | Dec 31, 2023 | -$36.49M | – |
| FY2022 | Dec 31, 2022 | -$49.57M | – |
| FY2021 | Dec 31, 2021 | -$36.80M | – |
| FY2020 | Dec 31, 2020 | -$19.24M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$18.36M | – |
| Q1 FY2026 | Mar 31, 2026 | -$170.60M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.93M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.82M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.17M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.24M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.14M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.68M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.65M | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.59M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.01M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.60M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.04M | – |
| Q1 FY2023 | Mar 31, 2023 | -$10.85M | – |
| Q4 FY2022 | Dec 31, 2022 | -$12.89M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.79M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.57M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.33M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.08M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.18M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.66M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.87M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.01M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.30M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.86M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.08M | – |
See a number that looks wrong?